Transfusion-related acute lung injury

European Journal of Anaesthesiology

Volumn 31, Issue 7, 2014, Pages 345-350

  Kenz, Hanane El ^a   Van Der Linden, Philippe ^a,b  

^a FREE UNIVERSITY OF BRUSSELS   (Belgium)

^b BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

OXYGEN;

ARTIFICIAL VENTILATION; ASSISTED VENTILATION; DIFFERENTIAL DIAGNOSIS; ECHOCARDIOGRAPHY; HUMAN; INCIDENCE; OXYGEN THERAPY; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; SYSTEMATIC REVIEW (TOPIC); THORAX RADIOGRAPHY; TRANSFUSION RELATED ACUTE LUNG INJURY; ACUTE LUNG INJURY; BLOOD TRANSFUSION; PLASMA; TIME;

ACUTE LUNG INJURY; BLOOD TRANSFUSION; HUMANS; INCIDENCE; PLASMA; TIME FACTORS;

EID: 84905448552     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0000000000000015     Document Type: Review

References (54)

1. Vamvakas EC, Blajchman MA. Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood 2009; 113:3406-3417.
2. Vamvakas EC. Establishing causation in transfusion medicine and related tribulations. Transfus Med Rev 2011; 25:81-88.
3. Luban NL. Transfusion safety: where are we today? Ann N Y Acad Sci 2005; 1054:325-341.
4. Vlaar AP, Hofstra JJ, Determann RM, et al. The incidence, risk factors, and outcome of transfusion-related acute lung injury in a cohort of cardiac surgery patients: a prospective nested case-control study. Blood 2011; 117:4218-4225.
5. Gajic O, Rana R, Winters JL, et al. Transfusion-related acute lung injury in the critically ill: prospective nested case-control study. Am J Resp Crit Care Medi 2007; 176:886-891.
6. Vlaar AP, Schultz MJ, Juffermans NP. Transfusion-related acute lung injury: a change of perspective. Neth J Med 2009; 67:320-326.
7. Kleinman S, Caulfield T, Chan P, et al. Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion 2004; 44:1774-1789.
8. Vlaar AP, Juffermans NP. Transfusion-related acute lung injury: a clinical review. Lancet 2013; 382:984-994.
9. Toy P, Gajic O, Bacchetti P, et al. Transfusion-related acute lung injury: incidence and risk factors. Blood 2012; 119:1757-1767.
10. Barnard RD. Indiscriminate transfusion: a critique of case reports illustrating hypersensitivity reactions. N Y State J Med 1951; 51:2399-2402.
11. Popovsky MA, Moore SB. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 1985; 25:573-577.
12. Vamvakas EC, Blajchman MA. Blood still kills: six strategies to further reduce allogeneic blood transfusion-related mortality. Transfus Med Rev 2010; 24:77-124.
13. Bernasinski M, Gette S, Malinovsky JM, et al. TRALI in the University Hospital of Nancy: a reevaluation of the incidence after applying strict criteria of Toronto. Transfus Clin Biol 2013; 20:40-45.
14. Vlaar AP. Transfusion-related acute lung injury: current understanding and preventive strategies. Transfus Clin Biol 2012; 19:117-124.
15. Toy P, Popovsky MA, Abraham E, et al. Transfusion related acute lung injury: definition and review. Crit Care Med 2005; 33:721-726.
16. Van der Linden P, Lambermont M, Dierick A, et al. Recommendations in the event of suspected transfusion-related acute lung injury (TRALI). Acta Clin Belg 2012; 67:201-208.
17. Goldman M, Webert KE, Arnold DM, et al. Proceedings of a consensus conference: towards an understanding of TRALI. Transfus Med Rev 2005; 19:2-31.
18. Triulzi DJ. Transfusion-related acute lung injury: an update. Hematology Am Soc Hematol Educ Program 2006;497-501.
19. Marik PE, Corwin HL. Acute lung injury following blood transfusion: expanding the definition. Crit Care Med 2008; 36: 3080-3084.
20. Silliman CC. The two-event model of transfusion-related acute lung injury. Crit Care Med 2006; 34:S124-S131.
21. Middelburg RA, Van Stein D, Zupanska B, et al. Female donors and transfusion-related acute lung injury: a case-referent study from the International TRALI Unisex Research Group. Transfusion 2010; 50:2447-2454.
22. Reil A, Keller-Stanislawski B, Gunay S, Bux J. Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors. Vox Sang 2008; 95:313-317.
23. Chapman CE, Stainsby D, Jones H, et al. Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion 2009; 49:440-452.
24. Middelburg RA, Porcelijn L, Lardy N, et al. Prevalence of leucocyte antibodies in the Dutch donor population. Vox Sang 2011; 100:327-335.
25. Hirayama F. Recent advances in laboratory assays for nonhemolytic transfusion reactions. Transfusion 2010; 50:252-263.
26. Bux J, Becker F, Seeger W, et al. Transfusion-related acute lung injury due to HLA-A2-specific antibodies in recipient and NB1-specific antibodies in donor blood. Br J Haematol 1996; 93:707-713.
27. Sachs UJ, Bux J. TRALI after the transfusion of cross-match-positive granulocytes. Transfusion 2003; 43:1683-1686.
28. Middelburg RA, van Stein D, Briet E, van der Bom JG. The role of donor antibodies in the pathogenesis of transfusion-related acute lung injury: a systematic review. Transfusion 2008; 48:2167-2176.
29. Ozier Y, Muller JY, Mertes PM, et al. Transfusion-related acute lung injury: reports to the French Hemovigilance Network 2007 through 2008. Transfusion 2011; 51:2102-2110.
30. Sachs UJ. Recent insights into the mechanism of TRALI. ISBT Sci Series 2013; 8:142-148.
31. Silliman CC, Kelher M. The role of endothelial activation in the pathogenesis of transfusion-related acute lung injury. Transfusion 2005; 45:109S- 116S.
32. Silliman CC, Moore EE, Kelher MR, et al. Identification of lipids that accumulate during the routine storage of prestorage leukoreduced red blood cells and cause acute lung injury. Transfusion 2011; 51:2549-2554.
33. Silliman CC, Voelkel NF, Allard JD, et al. Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J Clin Invest 1998; 101:1458-1467.
34. Maslanka K, Smolenska-Sym G, Michur H, et al. Lysophosphatidylcholines: bioactive lipids generated during storage of blood components. Arch Immunol Ther Exp (Warsz) 2012; 60:55-60.
35. Vlaar AP, Hofstra JJ, Levi M, et al. Supernatant of aged erythrocytes causes lung inflammation and coagulopathy in a 'two-hit' in vivo syngeneic transfusion model. Anesthesiology 2010; 113:92-103.
36. Vlaar AP, Hofstra JJ, Kulik W, et al. Supernatant of stored platelets causes lung inflammation and coagulopathy in a novel in vivo transfusion model. Blood 2010; 116:1360-1368.
37. Tuinman PR, Gerards MC, Jongsma G, et al. Lack of evidence of CD40 ligand involvement in transfusion-related acute lung injury. Clin Exp Immunol 2011; 165:278-284.
38. Silliman CC, Boshkov LK, Mehdizadehkashi Z, et al. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood 2003; 101:454-462.
39. Middelburg RA, Borkent B, Jansen M, et al. Storage time of blood products and transfusion-related acute lung injury. Transfusion 2012; 52:658-667.
40. Bux J, Sachs UJ. The pathogenesis of transfusion-related acute lung injury (TRALI). Br J Haematol 2007; 136:788-799.
41. Sachs UJ. Recent insights into the mechanism of transfusion-related acute lung injury. Curr Opin Hematol 2011; 18:436-442.
42. Looney MR, Nguyen JX, Hu Y, et al. Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury. J Clin Invest 2009; 119:3450-3461.
43. Renaudier P, Rebibo D, Waller C, et al. [Pulmonary complications of transfusion (TACO-TRALI)]. Transfus Clin Biol 2009; 16:218-232.
44. Ozier Y, Renaudier P, Caldani C, et al. Posttransfusion pulmonary oedema: the French hemovigilance network classification method. Transfus Clin Biol 2010; 17:284-290.
45. Ware LB, Matthay MA. Clinical practice. Acute pulmonary edema. N Engl J Med 2005; 353:2788-2796.
46. Bierling P, Bux J, Curtis B, et al. Recommendations of the ISBT Working Party on Granulocyte Immunobiology for leucocyte antibody screening in the investigation and prevention of antibody-mediated transfusion-related acute lung injury. Vox Sang 2009; 96:266-269.
47. Wheeler AP, Bernard GR. Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet 2007; 369:1553-1564.
48. Flesland O. A comparison of complication rates based on published haemovigilance data. Intensive Care Med 2007; 33 (Suppl 1):S17-S21.
49. Sachs UJ, Kauschat D, Bein G. White blood cell-reactive antibodies are undetectable in solvent/detergent plasma. Transfusion 2005; 45:1628-1631.
50. Maclennan S, Lucas G, Brown C, et al. Prevalence of HLA and HNA antibodies in donors: correlation with pregnancy and transfusion history. Vox Sang 2004; 87:S4.
51. Powers A, Stowell CP, Dzik WH, et al. Testing only donors with a prior history of pregnancy or transfusion is a logical and cost-effective transfusion-related acute lung injury prevention strategy. Transfusion 2008; 48:2549-2558.
52. Eder AF, Herron RM Jr, Strupp A, et al. Effective reduction of transfusionrelated acute lung injury risk with male-predominant plasma strategy in the American Red Cross (2006-2008). Transfusion 2010; 50:1732-1742.
53. Eder AF, Dy BA, Perez JM, et al. The residual risk of transfusion-related acute lung injury at the American Red Cross (2008-2011): limitations of a predominantly male-donor plasma mitigation strategy. Transfusion 2013; 53:1442-1449.
54. Tung JP, Fraser JF, Nataatmadja M, et al. Age of blood and recipient factors determine the severity of transfusion-related acute lung injury (TRALI). Crit Care 2012; 16:R19.